Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-Marketing Pharmacokinetic Study of EPZICOM Tablet in HIV-Infected Japanese Patients
jRCT1080220286Phase 4
- Sponsor
- GSK
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of abacavir + lamivudine in human immunodeficiency virus infection (HIV), sponsored by GSK. Primary endpoint: Pharmacokinetic parameters of lamivudine and abacavir.
02
Drugs
abacavir + lamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on jRCT1080220286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080220286.